Irene Becklund - Apr 4, 2023 Form 4 Insider Report for Hims & Hers Health, Inc. (HIMS)

Role
PAO
Signature
/s/ Alexandra Cotter Wilkins, Attorney-in-Fact
Stock symbol
HIMS
Transactions as of
Apr 4, 2023
Transactions value $
-$162,675
Form type
4
Date filed
4/6/2023, 05:59 PM
Previous filing
Mar 20, 2023
Next filing
May 8, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
transaction HIMS Class A Common Stock Sale -$158K -15.3K -100% $10.30 0 Apr 4, 2023 Direct F1
transaction HIMS Class A Common Stock Options Exercise $992 +567 $1.75 567 Apr 4, 2023 Direct F2
transaction HIMS Class A Common Stock Sale -$5.84K -567 -100% $10.30 0 Apr 4, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HIMS Stock Option (right to buy) Options Exercise $0 -567 -3.34% $0.00 16.4K Apr 4, 2023 Class A Common Stock 567 $1.75 Direct F3

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 11, 2022 by the Reporting Person.
F2 The stock option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 11, 2022 by the Reporting Person.
F3 25% of the shares of Class A common stock subject to the Stock Option vested on June 3, 2021 and the remaining 75% vest in a series of thirty-six successive equal monthly installments thereafter, subject to the Reporting Person's continuous service with the issuer.